Ex-Advanced Medical Optics CEO Mazzo indicted in insider trading case

September 25, 2014 By Brad Perriello Leave a Comment

UPDATED Sept. 25, 2014, with statement from Mazzo.

A federal grand jury today indicted former Advanced Medical Optics CEO James Mazzo on insider trading charges stemming from Abbott‘s (NYSE:ABT) $2.8 billion acquisition of AMO in 2009.

Mazzo, who denied the charges today via his lawyer, allegedly tipped off close friend and neighbor Doug DeCinces about the deal. DeCinces, a former baseball player for the Baltimore Orioles, allegedly passed the information on to former teammate Eddie Murray, who agreed to settle his case for $358,000 but admitted no wrongdoing. Today’s indictment levels 13 counts of insider trading violations against Mazzo, who is now chairman & CEO of AcuFocus and an operating partner at Versant Ventures.

In August 2012 the SEC slapped Mazzo and Murray with insider trading charges. The SEC also accused DeCinces of telling at least 4 others about the AMO/Abbott deal. DeCinces agreed to pony up $2.5 million in 2011 to settle SEC charges that he began purchasing AMO shares based on information from someone inside the company and tipped 3 others who also traded on the confidential information. DeCinces did not admit to any wrongdoing in the settlement.

"Mr. Mazzo flatly and unequivocally denies the government’s allegations. Mr. Mazzo has a spotless reputation for professionalism, integrity, and service to his community, built up over a career of 30 years. The notion that he would put all that at risk to give a single friend inside information is absurd. Any claim that he engaged in unlawful conduct is totally baseless," Mazzo‘s attorney, Richard Marmaro of of Skadden Arps Slate Meagher & Flom, told MassDevice.com via email. "The government has not alleged that Mr. Mazzo traded on inside information or profited from any trades by others. Nor has the government alleged any possible reason why Mr. Mazzo would have done so. Instead, the government claims that, for no apparent reason, he decided to give one friend nonpublic information about a corporate deal. The truth is that Mr. Mazzo never disclosed material, non-public information to Mr. DeCinces or any other investor – not to give a trading advantage to a friend, not for any reason."

The probe was spurred by the conviction of Galleon Management hedge fund founder Raj Rajaratnam (who was convicted last year of 14 counts of conspiracy and securities fraud and is serving an 11-year prison sentence). Investigators have turned up leaks about the Advanced Medical Optics deal from a number of sources, according to the news service, including people who worked for AMO, its law firm, Skadden Arps, and its merger adviser, Goldman Sachs Group. Other suspected leakers include Goldman Sachs managing partner Matthew Korenberg and Paul Yook, a former portfolio manager at Galleon.

DeviceTalks Weekly Podcast: Deconstructing medtech’s alphabet soup – DPA, MDR, FDA are all in the news
In this week’s DeviceTalks Weekly, we’ll examine how governmental effort, both foreign and domestic, are hitting the medtech industry. Our guests include Tracy Eberly, CEO of Fang Consulting, a regulatory advisory group. Eberly will update listeners on what pushing back the MDR deadline could mean for medtech companies and why some companies may be less than… […]
AdvaMed: Invoking Defense Production Act could hinder U.S. medtech imports
Forcing manufacturers to repurpose their production lines to make equipment to fight the coronavirus epidemic might actually hurt the U.S. supply of those items, the head of medtech trade group AdvaMed said today. AdvaMed officials have talked with U.S. secretary of Health and Human Services Alex Azar and FDA commissioner Dr. Stephen Hahn about medtech… […]
March 2020 Issue: Is software key to medical 3D printing innovation?
What’s the word on ethylene oxide? The coronavirus pandemic has pushed a lot of news out of people’s minds, but medtech has other big issues to deal with. For instance, 8 months have passed since the FDA issued a public challenge for alternatives to ethylene oxide (EtO) as a sterilant for medical devices. As I… […]
GE Healthcare quadruples ventilator production at Wisconsin plant
General Electric Healthcare (NYSE:GE) this week announced that it is doubling its production capacity for ventilators and expanding its Madison, Wisconsin, production line to 24-hour operation. In a report on GE’s website, the company shared that it has doubled its capacity of ventilator production with plans to double it again by the end of the second… […]
FDA issues FAQ on 3D-printed equipment against coronavirus
Intrepid 3D printing companies and individuals who want to print masks, gowns and other personal protective equipment (PPE) to fight the coronavirus pandemic might want to take a look at the FDA’s new frequently asked questions page on the topic. While it says it welcomes coronavirus-fighting efforts, the agency said that 3D-printed masks are unlikely… […]
Software is enabling medical 3D printing innovation: Here’s how
The 3D printers themselves get a lot of attention, but for 3D-printing to become ubiquitous in the medtech space, software will have to play a key role. A 3D printer without software to tell it where to place the material is a really nice, expensive coffee table, according to Scott Rader, a former Stratasys GM… […]
This open source ventilator hackathon could help fight the coronavirus
Infineon engineers developed a 3D printed lung ventilator to help address the shortage of ventilators due to the COVID-19 pandemic. The German federal government held a hackathon called #WirvsVirus (“We against the virus”) where 42,000 people met to find solutions to challenges from the coronavirus. Infineon engineers, led by Mahmoud Ismail who has a doctorate… […]
Could these DIY ventilators stop coronavirus from killing people?
Amid the global crisis caused by the coronavirus pandemic, hospitals and healthcare facilities are reporting shortages of vital equipment that not only keeps the patients safe, but the staffers, too. One important device for which demand has ramped up is ventilators for patients who need assistance with their breathing due to the respiratory effects of… […]
DIY ventilators? Not unless there’s a zombie apocalypse.
News reports of the COVID-19 virus have given a lot of space to the shortage of respiratory ventilators. The Society of Critical Care Medicine claims at least 950,000 U.S. patients could need ventilators but hospitals only have 160,000. One response to statistics like these has been a movement among open-source promoters to initiate community-designed ventilators… […]
FDA announces EUAs related to ventilators to treat coronavirus
Amid a shortage of ventilators for treating coronavirus, the FDA put out a statement confirming its stance on issuing emergency use authorizations for potential temporary fixes. The FDA said it is operating on the basis of a EUA determination that the U.S. Dept. of Health and Human Services issues on Feb. 4. Earlier this week, HHS declared… […]
Hack the Crisis: Life-saving pneumatics from Emerson’s ASCO and Aventics
As the United States continues to focus on social distancing to combat COVID-19, more companies are revealing how the move home for their workers is impacting their business. Despite this, companies like Emerson’s ASCO and Aventics divisions continue to step up production on key technologies used in life sciences and laboratories, including ventilators, respirators, hospital… […]